From: Biomarkers of food intake for nuts and vegetable oils: an extensive literature search
Dietary factor [reference] | Study design | Number of subjects | Analytical method | Sample type | Discriminating metabolites/candidate biomarkers |
---|---|---|---|---|---|
Olive oil [127] | Sustained intervention | 11 | GC-FID | Erythrocytes | Oleic acid |
Olive oil [128] | Sustained intervention | 12 | GC-FID | Plasma | Oleic acid |
Olive oila [129] | Sustained intervention | 30 | GC-FID | Plasma | Oleic acid |
Olive oil [130] | Sustained intervention | 21 | GC-FID | Plasma/platelets | Oleic acid |
Olive oil [131] | Sustained intervention | 16 | GC-FID | Erythrocytes | Oleic acid |
Olive oil | Sustained intervention | 30 | GC-FID | Plasma/PBMC | Oleic acid |
Olive oil, extra virgin [133] | Acute study | 10 | GC | Plasma—TAG | Oleic acid |
Olive oil, pomace and refined [134] | Acute study | 10 | GC | Serum—TRL | Oleic acid |
Olive oil, virgina [135] | Acute study | 11 | UPLC-MS; GC-MS | Urine | Hydroxytyrosol |
Olive oil, different phenolic contenta [136] | Acute study | 12 | GC-MS | Urine | Hydroxytyrosol, 3-O-methy-hydroxytyrosol |
Olive oil, enriched or virgina [137] | Acute study | 13 | UPLC-MS/MS | Plasma | Hydroxytyrosol sulfate |
Olive oil, virgin [138] | Acute study | 13 | UPLC-MS/MS | Plasma | Hydroxytyrosol sulfate |
Olive oil, high phenolic content [139] | Acute study | 12 | UPLC-MS/MS | Plasma | Hydroxytyrosol sulfate, hydroxytyrosol acetate sulfate |
Olive oil, virgin, moderate and high phenolic content [140] | Acute study | 13 | UPLC-MS/MS | Plasma | Hydroxytyrosol sulfate, hydroxytyrosol acetate sulfate |
Olive oil, extra virgin [141] | Sustained intervention | 10 | GC-FID | Plasma and cells | Oleic acid |
Olive oil, extra virgin [142] | Sustained intervention | 424 | GC | Plasma | Oleic acid |
Olive oil, different phenolica compound content [143] | Sustained intervention | 30 | GC-MS | Urine | Hydroxytyrosol |
Olive oil, different phenol contenta [144] | Sustained intervention | 200 | GC-MS | Urine | Hydroxytyrosol |
Olive oil, high-phenol vs low-phenol extra virgina [145] | Sustained intervention | 10 | GC-MS | Urine | Hydroxytyrosol |
Olive oils, different phenolic contenta [146] | Sustained intervention | 30 | HPLC | Urine | Hydroxytyrosol |
Olive oil, different phenolic contenta [147] | Sustained intervention | 38 | GC-MS | Urine | Hydroxytyrosol |
Olive oil, refined, common and virgina [148] | Sustained intervention | 33 | HPLC | Urine | Hydroxytyrosol |
Olive oil, extra virgina [149] | Sustained intervention | 20 | HPLC-MS | Plasma | Hydroxytyrosol |
Olive oil, extra virgin [80] | Sustained intervention | 750 | GC-MS | Urine | Hydroxytyrosol |
Olive oil, different phenolic compound contenta [150] | Sustained intervention | 28 | GC-MS | Urine | Hydroxytyrosol, O-methylhydroxytyrosol |
Olive oil, with different phenolic contentsa [151] | Sustained intervention | 182 | GC-MS/MS | Urine | Hydroxytyrosol, 3-O-methylhydroxytyrosol |
Olive oil, virgin and refineda [152] | Sustained intervention | 36 | HPLC-MS/MS | Plasma-LDL | Hydroxytyrosol sulfate |
Olive oil, virgin, enriched [153] | Sustained intervention | 33 | UHPLC-MS/MS | Urine | Hydroxytyrosol sulfate |
Olive oil, high polyphenol contenta [154] | Sustained intervention | 51 | UHPLC-MS/MS | Plasma-HDL | Hydroxytyrosol sulfate |
Olive oil, virgin, high phenolica [155] | Sustained intervention | 5 | UPLC-MS/MS | Urine | Hydroxytyrosol sulfate, hydroxytyrosol acetate sulfate |
Olive oil, virgin, enriched [156] | Sustained intervention | 33 | UPLC-MS/MS | Plasma/urine | Hydroxytyrosol sulfate, hydroxytyrosol acetate sulfate |
Olive oil, virgin (OO); rapeseed oil (RO); sunflower oil (SO) [157] | Sustained intervention | 18 | GC-FID | Plasma | Oleic acid (OO, RO), linoleic acid (SO, RO) |
Olive oil (OO), canola oil (CO) a [158] | Sustained intervention | 14 | GC-FID | Plasma | Oleic acid (OO, α-Linolenic acid (CO) |
Flaxseed oil [159] | Sustained intervention | 16 | GC-FID | Plasma/PBMC | α-Linolenic acid |
Flaxseed oil [160] | Sustained intervention | 30 | GC-FID | Plasma | α-Linolenic acid |
Flaxseed oil [161] | Sustained intervention | 46 | GC-FID | Platelets | α-Linolenic acid |
Flaxseed oil [162] | Sustained intervention | 28 | GC-FID | Plasma | α-Linolenic acid |
Flaxseed oil [163] | Sustained intervention | 17 | GC-FID | Plasma/platelets | α-Linolenic acid |
Flaxseed oil [164] | Sustained intervention | 20 | GC | Plasma/erythrocytes | α-Linolenic acid |
Flaxseed oil [165] | Sustained intervention | 51 | GC | Erythrocytes | α-Linolenic acid |
Flaxseed oil [166] | Sustained intervention | 62 | GLC | Erythrocytes | α-Linolenic acid |
Flaxseed oil [167] | Sustained intervention | 86 | GC | Plasma | α-Linolenic acid |
Flaxseed oil [168] | Sustained intervention | 34 | GC | Plasma | α-Linolenic acid |
Flaxseed oil [169] | Sustained intervention | 98 | GC | Erythrocytes | α-Linolenic acid |
Flaxseed oil [170] | Sustained intervention | 26 | GC-FID | Plasma | α-Linolenic acid |
Flaxseed oil [171] | Sustained intervention | 37 | GC | Erythrocytes | α-Linolenic acid |
Flaxseed oil [172] | Sustained intervention | 15 | GC-FID | Serum | α-Linolenic acid |
Flaxseed oil (FO); sunflower oil (SO) [173] | Sustained intervention | 10 | GC-FID | Platelets | α-Linolenic acid (FO); linoleic acid (SO) |
Rapeseed oil [177] | Sustained intervention | 40 | GC-FID | Plasma | α-Linolenic acid |
Canola oila [174] | Sustained intervention | 14 | GC-FID | Breastmilk | α-Linolenic acid |
Canola oil [175] | Sustained intervention | 130 | GC-FID | Plasma | α-Linolenic acid |
Canola oil [176] | Sustained intervention | 130 | GC-FID | Plasma | α-Linolenic acid |
Canola oil (CO); sunflower oil (SO) a [178] | Sustained intervention | 8 | GC-FID | Plasma | α-Linolenic acid (CO); linoleic acid (SO) |
Canola oil (CO); sunflower oil (SO) [179] | Sustained intervention | 8 | GC-FID | Platelets | α-Linolenic acid (CO); linoleic acid (SO) |
Sunflower oil [180] | Sustained intervention | 37 | GC | Plasma-CE/ASAT | Linoleic acid |